The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 3, 2002, Pages 515-520

  Kokkola, A ^a,e   Sipponen, P ^b   Rautelin, H ^c   Harkonen M ^d   Kosunen, T U ^c   Haapiainen, R ^a   Puolakkainen, P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JORVI HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Biohit Oyj   (Finland)

^e Meilahti Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIUM ANTIBODY; LANSOPRAZOLE; METRONIDAZOLE; PEPSINOGEN I;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSPLASIA; ENDOSCOPY; ERADICATION THERAPY; GASTRITIS; GASTROSCOPY; HEALING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; STOMACH LESION; STOMACH MUCOSA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DRUG COMBINATIONS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; SEROLOGIC TESTS;

EID: 0036188340     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01214.x     Document Type: Article

References (34)

1. How is Helicobacter pylori transmitted?
2. Long-term sequelae of Helicobacter pylori gastritis
3. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study
4. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis
5. Is Helicobacter pylori involved in the pathogenesis of the gastritis characteristic of pernicious anaemia? Comparison between pernicious anaemia relatives and duodenal ulcer relatives
6. Relationship between Helicobacter pylori, gastric parietal cell antibodies and heat shock proteins
7. Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations
8. Simple atrophic gastritis and gastric carcinoma
9. Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of crosssectional data
10. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts
11. Helicobacter pylori-associated gastritis. Evolution of histologic changes over 10 years
12. Campyobacter pylaridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment
13. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study
14. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
15. Significant improvement of atrophy after eradication therapy in atrophic body gastritis
16. Reversal of fundic atrophy after eradication of Helicobacter pylori
17. Helicobacter pylori infection and chronic gastric acid hyposecretion
18. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study
19. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori
20. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinaemia and its related effects on body ECL-cell hyperplasia
21. Gastritis - Atrophic gastritis - Intestinal metaplasia - Cancer of the stomach: Is this sequence reversible?
22. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia
23. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia
24. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
25. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: A follow up study
26. The Sydney system: Histological division
27. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres alter eradication of Helicobacter pylori
28. Evaluation of Pyloriset screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection
29. Effect of Helicobacter pylori infection and its eradication on cell proliferation. DNA status, and oncogene expression in patients with chronic gastritis
30. Atrophy, metaplasia and dysplasia: Are they reversible?
31. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis
32. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: Comparison of histology, 13C-urea breath test, and serology
33. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis